Searchable abstracts of presentations at key conferences in endocrinology

ea0003p153 | Genetics | BES2002

Lack of association of the insulin gene region with Grave's disease in the UK

Tait K , Collins J , Heward J , Allahbadia A , Barnett A , Franklyn J , Gough S

Graves' disease and type 1 diabetes frequently occur together and this would suggest that genetic susceptibility is due to common loci. The insulin (INS) gene region (IDDM2) on chromosome 11p15.5 is linked to, and associated with, type 1 diabetes and it has been suggested that it may be acting as a general autoimmunity locus. Susceptibility is conferred by the variable number of tandem repeats (VNTR); a polymorphic region situated 5' to the INS gene. The class I/I homozygote g...

ea0063p1049 | Pituitary and Neuroendocrinology 3 | ECE2019

Expression of programmed death ligand 1 (PD-L1) in human pituitary adenomas

Suteau Valentine , Collin Alexandre , Menei Philippe , Rodien Patrice , Rousselet Marie-Christine , Briet Claire

Introduction: Pituitary adenomas, second most common brain tumors, are mostly well controlled after surgery. However, some pituitary tumors present an aggressive evolution and are resistant to standard management. Immunotherapy with inhibitors of T-cell checkpoints have shown durable efficacy in a variety of malignancies. Moreover, immunotherapy has been associated with treatment-related hypophysitis, suggesting that pituitary could be a target of these treatments. Recently, i...

ea0090rc8.4 | Rapid Communications 8: Calcium and Bone | ECE2023

Encaleret (CLTX-305) normalized mineral homeostasis parameters in patients with autosomal dominant hypocalcemia type 1: Results over 12 months in a phase 2 study (NCT04581629)

Collins Michael , Hartley Iris , Roszko Kelly , Nemeth Edward , Pozo Karen , Boykin Winsome , Mathew Arun , Roberts Mary Scott , Adler Scott

Autosomal dominant hypocalcemia type 1 (ADH1), caused by gain-of-function calcium-sensing receptor gene (CASR) variants, is characterized by low parathyroid hormone (PTH) levels, hypocalcemia, hypercalciuria, hyperphosphatemia and hypomagnesemia. Conventional therapy (calcium and active vitamin D) worsens hypercalciuria, which may result in renal complications. Calcilytics, such as encaleret, are negative allosteric modulators of the calcium-sensing receptor (CaSR). T...

ea0044oc6.6 | Pregnancy and Reproductive Health | SFEBES2016

Defining the metabolic phenotype of peritoneal mesothelial cells from women with endometriosis

Ahmad Syed F , Carter Roderick N , Collins Frances , Greaves Erin , Morton Nicholas M , Saunders Philippa TK , Horne Andrew W

Endometriosis is a chronic oestrogen-dependent incurable inflammatory disorder, defined by the presence of endometrial-like tissue outside the uterine cavity that affects 6–10% of women of reproductive age. It is associated with debilitating pelvic pain and subfertility with a significant impact on quality of life and estimated annual costs to the UK of £11.7 billion. Recent findings from our laboratory have shown that there is a shift in cell metabolism from mitocho...

ea0058p050 | Diabetes | BSPED2018

A survey of the use of medical identification in children and young people with diabetes at a large children’s hospital

Yorke Jessica , Drummond Lesley , Collins Louise , Sands Donna , Krone Ruth , Saraff Vrinda , Dias Renuka , Barrett Timothy , Kershaw Melanie

Objectives: Children and young people (CYP) with Type 1 Diabetes Mellitus (T1DM) are at risk of acute clinical emergencies. Wearing medical identification (ID) is recommended by the National Institute for Clinical excellence (NICE). Information on adherence to this recommendation in CYP with T1DM is scarce. This study aimed to assess parent and CYP’s knowledge of the recommendation, to explore adherence and barriers to carrying ID and understand preferred forms of ID....

ea0070aep52 | Adrenal and Cardiovascular Endocrinology | ECE2020

Ambulance alert system enabling pre-hospital parenteral steroids for patients with adrenal insufficiency

Westall Sam , Sullivan Heather , Rawsthorne Emma , Beesley Carl , Collins John , Furlong Niall , McNulty Steven , Bujawansa Sumudu , Narayanan Ram Prakash

Background: For patients in an adrenal crisis, the timely administration of parenteral hydrocortisone can be life-saving. Data from the Addison’s Disease Self-Help Group found that a large proportion of adrenal crises occur out of hospital, with many patients relying on the emergency services for initial parenteral hydrocortisone administration. Despite regular patient education (including parenteral hydrocortisone self-administration) and recommendations to wear steroid...

ea0095oc7.5 | Oral Communications 7 | BSPED2023

Leicester Paediatric Diabetes Unit’s ‘Bridge the Gap’ project: Improving access to diabetes technology for children and young people from ethnic minorities and socio-economically deprived families

Chandwani Manju , Collins Michele , Kazi Farah , Heath Laura , Mayes Aan , Sparrow Katy , Jeffrey Megan , Patel Khadija , Sundaram Prem

The National Paediatric Diabetes Audit 2021 uncovered widening disparity in the utilisation of diabetes technologies among children and young people (CYP) with type 1 diabetes from ethnic minorities and low socioeconomic groups. Our data revealed that only 27.5% of CYP from ethnic minorities were using insulin pump therapy, compared to 50% from a white background. Unfortunately, our current staffing levels and available resources were inadequate to address this issue effective...

ea0090oc3.4 | Oral Communications 3: Pituitary and Neuroendocrinology 1 | ECE2023

Measurements of growth hormone using dried blood spots in preterm neonates: reference values and longitudinal evaluation.

Giacchetti Federico , Vidali Matteo , Orsenigo Chiara , Vizzari Giulia , Tarricone Silvia , Vantaggiato Chiara , Rodari Giulia , Modugno Adriana Di , Napolitano Filomena , Sangiorgio Andrea , Morniroli Daniela , Colombo Lorenzo , Profka Eriselda , Collini Valentina , Gianni Maria Lorella , Mantovani Giovanna , Mosca Fabio , Ceriotti Ferruccio , Arosio Maura , Giavoli Claudia

Background and Aim: Congenital growth hormone deficiency (cGHD) is a rare but life-threatening condition whose diagnosis is challenging in the absence of reliable reference values, both in healthy neonates and in preterm ones. We recently estimated GH reference interval in 1036 healthy, at-term newborns (HN) form dried blood spot samples using a previously validated analytical method. Aim of this study is to provide values for random GH in preterm newborns (PN).<p class="a...

ea0081rc8.2 | Rapid Communications 8: Calcium and Bone | ECE2022

Temporal effects of encaleret (CLTX-305) on mineral physiology in autosomal dominant hypocalcemia type 1 (ADH1): results from a phase 2B, open-label, dose-ranging study [NCT04581629]

Gafni Rachel , Hartley Iris , Roszko Kelly , Pozo Karen , Nemeth Edward , Sani-Grosso Ramei , Mathew Arun , Sridhar Ananth , Scott Roberts Mary , Fox Jonathan , Collins Michael

Autosomal dominant hypocalcemia type 1 (ADH1), caused by gain-of-function variants in the calcium-sensing receptor (CaSR, gene: CASR) and is characterized by hypocalcemia, hyperphosphatemia, low parathyroid hormone (PTH), and hypercalciuria. Calcilytics (negative allosteric modulators of the CaSR) decrease the sensitivity of activated receptors to extracellular calcium and normalize blood and urine abnormalities in ADH1 rodent models. Encaleret is an oral calcilytic u...

ea0085p65 | Diabetes 3 | BSPED2022

Use of artificial pancreas systems in routine clinical care is effective in improving glycaemic control in paediatric patients

Kaninde Abhidhamma , Kotak Janki , Collins Louise , Drummond Lesley , Pemberton John , Idkowiak Jan , Mohamed Zainaba , Dias Renuka , Saraff Vrinda , Kershaw Melanie , Krone Ruth

Introduction: Artificial pancreas systems (APS) have improved glycaemic control in adult and paediatric patients in clinical trials as part of routine clinical careAim and objectives: To evaluate the effectiveness of artificial pancreas system in routine clinical care on glycaemic control over a period of three to six months. Changes in glycated haemoglobin (HbA1c), time in range (TIR, 3.9-10 mmol/l) and time below range (TBR, <3.9 mmol/l) were asses...